Skip to content

Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID

Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04639349
Enrollment
40
Registered
2020-11-20
Start date
2020-11-19
Completion date
2021-03-01
Last updated
2020-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Detailed description

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients): the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks. The control group will not be trained

Interventions

BEHAVIORALexercise group

the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.

OTHERcontrol group

the control group will not be trained

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* stable COPD patients * patients who will have a training device as bicycle or treadmill in home

Exclusion criteria

* diabetic patients * renal patients. * liver diseases

Design outcomes

Primary

MeasureTime frameDescription
cortisolIt will be measured after eight weeks of trainingit will be measured in plasma
hospital anxiety and depression scaleIt will be measured after eight weeks of trainingthis a questionnaire that will assess anxiety and depression in COPD patients

Secondary

MeasureTime frameDescription
Interleukin-8It will be measured after eight weeks of trainingIt is an inflammatory marker in plasma
St. George's respiratory questionnaireIt will be measured after eight weeks of trainingIt assess the effect of COPD on general quality of life
six minute walking testIt will be measured after eight weeks of trainingit assess functional capacity
body mass indexIt will be measured after eight weeks of trainingit will measure body mass changes
pulmonary function testIt will be measured after eight weeks of trainingit will be a measurement for lung volume and capacities

Countries

Egypt

Contacts

Primary ContactAli Ismail, lecturer
allooka2012@gmail.com02 01005154209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026